CrowdStrike Unusual Options Activity Points to Bearish Hedge as CRWD Trades Near 52-Week High

May 11, 2026

By TrendSpider Editor

CrowdStrike Unusual Options Activity Points to Bearish Hedge as CRWD Trades Near 52-Week High

CrowdStrike Holdings, Inc. (CRWD) is seeing notable unusual options activity today, Monday, May 11, 2026, with a dominant put contract carrying $3,576,500 in premium flagged on the session. Shares are currently trading at $539.88, up 2.29% on the day, sitting comfortably above the midpoint of their 52-week range of $342.72 to $566.90. The options flow, totaling $3,909,629.60 in combined premium across two contracts, reflects a split sentiment picture with the put side carrying the overwhelming weight of the activity.

Key Drivers of the CRWD Stock Move

Main Catalyst: Two unusual options contracts were flagged today with a total premium of $3,909,629.60. The dominant trade is a PUT at the $500 strike expiring January 15, 2027, with a size of 575 contracts and an open interest reading of 90%. On the other side, a CALL at the $680 strike expiring November 20, 2026, traded 96 contracts with an extraordinary open interest reading of 9,600%.
Bull Case: The $680 call, while smaller in premium at $333,129.60, reflects a deeply out-of-the-money bet that CRWD could rally well beyond its current 52-week high of $566.90 by November 2026. The 9,600% open interest reading suggests this strike had virtually no prior activity, meaning fresh, conviction-driven positioning is entering the market on the upside.
Bear Case: The $500 put expiring January 15, 2027, accounts for $3,576,500 of the total $3,909,629.60 in premium flagged today, making it the dominant trade by a wide margin. At a size of 575 contracts and an open interest reading of just 90%, this appears to be a large, directional hedge or outright bearish bet that CRWD could retreat below $500, roughly 7.4% below the current price, within the next eight months.

The forward setup for CRWD is one of tension between strong price momentum and meaningful downside hedging activity. Shares are trading near the upper end of their 52-week range of $342.72 to $566.90, which may be prompting institutional players to buy downside protection even as the stock grinds higher. The January 2027 expiration on the put gives the position significant time to play out, suggesting this is not a short-term tactical trade but a longer-horizon hedge against a potential pullback from elevated levels. With the stock up 2.29% today alone and approaching its 52-week high of $566.90, the risk-reward calculus for protective positioning is a natural conversation in the market.

CRWD Unusual Options Activity

Two unusual contracts were flagged in today's session, representing a combined $3,909,629.60 in total premium:

Contract 1: CALL | Strike: $680 | Expiry: November 20, 2026 | Volume: 96 | Open Interest: 9,600% | OTM
Contract 2: PUT | Strike: $500 | Expiry: January 15, 2027 | Volume: 575 | Open Interest: 90% | OTM

Both contracts are out-of-the-money relative to the current price of $539.88. The put contract at $500 represents the clear dominant trade in terms of premium deployed, while the call contract's extraordinary open interest reading of 9,600% flags it as a high-conviction new position at an unusually elevated strike target.

CRWD Seasonality

May has historically been a transitional month for technology and cybersecurity names, often setting the tone heading into the summer period. With the January 2027 put expiration covering a full eight months of potential price action, the positioning captures multiple earnings cycles and macro events that could influence CRWD's trajectory from current levels near its 52-week high.

CRWD Relative Performance

CRWD's 2.29% gain today places it at $539.88, well above the midpoint of its 52-week range of $342.72 to $566.90, and within roughly 5% of its annual peak. The stock's proximity to the $566.90 52-week high suggests relative strength compared to broad technology peers, though the weight of today's options premium flowing into downside protection signals that at least some large participants are not complacent about the risk of a near-term reversal from these elevated levels.